Evidence map›Paper›PMID 24639348›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2014

Chemokine cooperativity is caused by competitive glycosaminoglycan binding.

Folkert Verkaar, Jody van Offenbeek, Miranda M C van der Lee, Lambertus H C J van Lith, Anne O Watts, Angelique L W M M Rops, David C Aguilar, Joshua J Ziarek, Johan van der Vlag, Tracy M Handel and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Article
  3. Atypical chemokine receptors in the immune system.Nature reviews. Immunology · 2024
    Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. CCL18 in the Progression of Cancer.International journal of molecular sciences · 2020
    Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Chemokines from a Structural Perspective.International journal of molecular sciences · 2017
    Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 8 institutions in 3 countries.

Folkert VerkaarDivision of Medicinal Chemistry, Faculty of Sciences, VU University Amsterdam, Amsterdam, The Netherlands.
Jody van OffenbeekDivision of Medicinal Chemistry, Faculty of Sciences, VU University Amsterdam, Amsterdam, The Netherlands.
Miranda M C van der LeeMerck Research Laboratories, Molecular Pharmacology & DMPK, Oss, The Netherlands.
Lambertus H C J van LithMerck Research Laboratories, Molecular Pharmacology & DMPK, Oss, The Netherlands.
Anne O WattsDivision of Medicinal Chemistry, Faculty of Sciences, VU University Amsterdam, Amsterdam, The Netherlands.
Angelique L W M M RopsDepartment of Nephrology, Radboud University Medical Centre, Nijmegen, The Netherlands.
David C AguilarSkaggs School of Pharmacy and Pharmaceutical Sciences, University of California, La Jolla, CA, USA.
Joshua J ZiarekDepartment of Biochemistry, Medical College of Wisconsin, Milwaukee, WI, USA.
Johan van der VlagDepartment of Nephrology, Radboud University Medical Centre, Nijmegen, The Netherlands.
Tracy M HandelSkaggs School of Pharmacy and Pharmaceutical Sciences, University of California, La Jolla, CA, USA.
Brian F VolkmanDepartment of Biochemistry, Medical College of Wisconsin, Milwaukee, WI, USA.
Amanda E I ProudfootMerck Serono Geneva Research Centre, Geneva, Switzerland.
Henry F VischerDivision of Medicinal Chemistry, Faculty of Sciences, VU University Amsterdam, Amsterdam, The Netherlands.
Guido J R Zaman *Netherlands Translational Research Center B.V. (NTRC), Oss, The Netherlands.
Martine J Smit *Division of Medicinal Chemistry, Faculty of Sciences, VU University Amsterdam, Amsterdam, The Netherlands.
Merck (Netherlands) · NLAmsterdam UMC Location VUmc · NLMedical College of Wisconsin · USRadboud University Medical Center · NLUniversity of Montana · USVrije Universiteit Amsterdam · NLCenter for Translational Molecular Medicine · NLMerck Serono (Switzerland) · CH

Funding

UCSD/SDSU IRACDAK12GM068524 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI TREJO, JOANN · 2003 to 2025
$24.4M
STRUCTURE OF MACROPHAGE CHEMOTACTIC ACTIVATING PROTEINSR01AI037113 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI HANDEL, TRACY M · 1995 to 2015
$5.2M
Structural Basis for Chemokine FunctionR01AI058072 · NIAID · MEDICAL COLLEGE OF WISCONSIN · PI VOLKMAN, BRIAN F · 2004 to 2019
$4.1M
Structural Basis for Chemokine FunctionR37AI058072 · NIAID · MEDICAL COLLEGE OF WISCONSIN · PI Brian F Volkman · 2020 to 2026
$2.8M
NIAID NIH HHS R01 AI037113NIAID NIH HHS R01 AI058072NIAID NIH HHS R01 AI37113NIAID NIH HHS R37 AI058072NIGMS NIH HHS K12 GM068524
6 · The paper itself

Abstract

Chemokines comprise a family of secreted proteins that activate G protein-coupled chemokine receptors and thereby control the migration of leukocytes during inflammation or immune surveillance. The positional information required for such migratory behavior is governed by the binding of chemokines to membrane-tethered glycosaminoglycans (GAGs), which establishes a chemokine concentration gradient. An often observed but incompletely understood behavior of chemokines is the ability of unrelated chemokines to enhance the potency with which another chemokine subtype can activate its cognate receptor. This phenomenon has been demonstrated to occur between many chemokine combinations and across several model systems and has been dubbed chemokine cooperativity. In this study, we have used GAG binding-deficient chemokine mutants and cell-based functional (migration) assays to demonstrate that chemokine cooperativity is caused by competitive binding of chemokines to GAGs. This mechanistic explanation of chemokine cooperativity provides insight into chemokine gradient formation in the context of inflammation, in which multiple chemokines are secreted simultaneously.

Indexed as

AnimalsBinding, CompetitiveChemokine CCL19Chemokine CCL21Chemokine CXCL13ChemokinesChemotaxisCHO CellsCricetinaeCricetulusGlycosaminoglycansModels, BiologicalProtein BindingProtein MultimerizationReceptors, ChemokineChemokine CCL19Chemokine CCL21Chemokine CXCL13ChemokinesGlycosaminoglycansReceptors, Chemokine

Identifiers

PMID24639348
PMCPMC4198333
OpenAlexW1943679088

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.